{"SPADE_N_04831": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2009/0105151 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2009_0105151_A1", "Patent Type": "Patent Application", "Publication Date": "2009-4-23", "Family Info": "WO2009014615A2,WO2009014615A3", "Patent Title": "Amphipathic alpha-helical peptide compositions as antiviral agents.", "Abstract": "The invention features methods and compositions that exploit the ability of amphipathic alpha-helical (AH) peptides to cause disruption of lipid-containing vesicles, such as enveloped viruses, in a size-dependent manner."}], "Sequence Information": {"SPADE ID": "SPADE_N_04831", "Sequence": "WLYDIVNWVCTVLADFKLWLGAKI", "Sequence Length": 24, "Peptide Name": "Sequence 20 from Patent US 20090105151", "Source": "Hepatitis C virus", "Biological Activity": ["Antimicrobial", "Antiviral"], "Frequent Amino Acids": "LVW", "Absent Amino Acids": "EHMOPQRSU", "Basic Residues": 2, "Acidic Residues": 2, "Hydrophobic Residues": 16, "Polar Residues": 11, "Positive Residues": 2, "Negative Residues": 2, "Mass": 2867.41, "PI": 5.95, "Net Charge": 0, "Hydrophobicity": 0.93, "Similar Sequences": [{"SPADE_ID": "SPADE_N_04840", "Similarity": 1.0, "Sequence": "SWLYDIVNWVCTVLADFKLWLGAKI"}, {"SPADE_ID": "SPADE_N_04850", "Similarity": 1.0, "Sequence": "SGSWLYDIVNWVCTVLADFKLWLGAKI"}, {"SPADE_ID": "SPADE_N_04859", "Similarity": 1.0, "Sequence": "GSWLYDIVNWVCTVLADFKLWLGAKI"}]}}}